KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ugi (UGI) Accumulated Expenses (2016 - 2025)

Ugi's Accumulated Expenses history spans 17 years, with the latest figure at $203.0 million for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses rose 3.57% year-over-year to $203.0 million, compared with a TTM value of $203.0 million through Sep 2025, up 3.57%, and an annual FY2025 reading of $203.0 million, up 3.57% over the prior year.
  • Accumulated Expenses for Q3 2025 was $203.0 million at Ugi, up from $196.0 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $203.0 million in Q3 2025, with the low at $142.0 million in Q3 2023.
  • Average Accumulated Expenses over 5 years is $173.8 million, with a median of $181.0 million recorded in 2021.
  • Year-over-year, Accumulated Expenses decreased 18.78% in 2022 and then soared 38.03% in 2024.
  • Tracing UGI's Accumulated Expenses over 5 years: stood at $181.0 million in 2021, then decreased by 18.78% to $147.0 million in 2022, then dropped by 3.4% to $142.0 million in 2023, then soared by 38.03% to $196.0 million in 2024, then rose by 3.57% to $203.0 million in 2025.
  • Per Business Quant, the three most recent readings for UGI's Accumulated Expenses are $203.0 million (Q3 2025), $196.0 million (Q3 2024), and $142.0 million (Q3 2023).